|
|
||||||||
The Annals of Thoracic Surgery, Vol 34, 34-39, Copyright © 1982 by The Society of Thoracic Surgeons
MM Kirsh, J Tashian and H Sloan
The 5-year survival of 293 men and of 78 women undergoing pulmonary
resection and mediastinal lymph node dissection is compared. These patients
were broken into two age groups: Group 1, 40 through 49 years of age, and
Group 2, 50 years of age and older. They were subdivided further according
to clinical stage, cell type, and sex. Of the 25 men in Group 1, 15 (60%)
survived 5 years, while 98 (37%) of the 268 men in Group 2 survived 5
years. Among the 31 women in Group 1, 5 (16%) survived for 5 years, while
15 (32%) of the 47 women in Group 2 survived for that length of time. The
survival among women in the younger age group was significantly lower than
for both groups of women in the older age group (p = 0.0335) and men in the
younger age group (p = 0.0033). This is believed to be due to the higher
incidence of both Stage III disease and adenocarcinoma in the younger
women. Twenty-two of the younger women (71%) were classified Stage III
compared with 14 (30%) of the older women. Fourteen younger men (56%) had
reached Stage III, and 101 older men (38%) were classified as Stage III.
These data suggest that sex is an important factor in determining survival
because there appears to be a relationship between it and the stage of the
disease, and cell type. Overall, women had a poorer 5-year survival than
men. Younger women have a strikingly lower survival than any other group,
which is explained by their higher incidence of both Stage III
classification and adenocarcinoma.
ARTICLES
Carcinoma of the lung in women
This article has been cited by other articles:
![]() |
C.-T. Wu, Y.-L. Chang, J.-Y. Shih, and Y.-C. Lee The significance of estrogen receptor {beta} in 301 surgically treated non-small cell lung cancers J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 979 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Barnes The Changing Face of Lung Cancer Chest, December 1, 2004; 126(6): 1718 - 1721. [Full Text] [PDF] |
||||
![]() |
E. Radzikowska, P. Glaz, and K. Roszkowski Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases Ann. Onc., July 1, 2002; 13(7): 1087 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Minami, M. Yoshimura, Y. Miyamoto, H. Matsuoka, and N. Tsubota Lung Cancer in Women : Sex-Associated Differences in Survival of Patients Undergoing Resection for Lung Cancer Chest, December 1, 2000; 118(6): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |